Summary. , a novel and potent cardiotonic agent, exhibits its effects by prolonging the open state of Na ÷ channels, resulting in an increase in action potential duration, and thus, is supposed to share the class III antiarrhythmic activity. The effects of DPI on the hemodynamics, intraventricular conduction and refractoriness of heart, and the incidence of arrhythmias induced by programmed electrical ventricular stimulation (PES) were compared with (___)-dobutamine. Dogs which survived for 5 to 7 days after the induction of myocardial infarction were used as the model. The presence of subacute myocardial infarction caused by occluding the left anterior descending coronary artery elicited a mild left ventricular dysfunction represented by a significant decrease in peak LV dp/dt by about 20%.
Introduction
The use of cardiotonic agents in the therapy of heart failure remains controversial (LeJemtel and Sonnenblick 1984) , because there is still the uncertainty about the occurrence of adverse effects such as malignant ventricular arrhythmias due to these agents (Cody 1988; Packer 1989) . Recently, many of the newer cardiotonic agents including/%adrenoceptor agonists and phosphodiesterase inhibitors, have been applied for the treatment of patients with heart failure. However, clinical reports (Krell et al. 1986; Packer et al. 1984) suggest that these newer agents are not necessarily free from promotion or aggravation of ventricular arrhythmias. Basic experimental studies (Lubbe et al. 1978; Clusin et al. 1982) have also indicated that these agents are associated with the development of ventricular arrhythmias by increasing intracellular adenosine 3',5'-monophosphate (cAMP) and calcium levels which mediate their positive inotropic actions. DPI 201-106 (DPI) is a diphenylmethylpiperazinyl-indole derivative with positive inotropic action in experimental animals (Scholtysik et al. 1985 (Scholtysik et al. , 1989 Salzmann et al. 1986 ) and in humans (Thormann et al. 1986 ; Kostis et al. 1987; Hogan et al. 1988) . The mechanism of its inotropic action has been considered to involve a prolongation of the open state of the sodium channel (Kohlhardt et al. 1986) , resulting in an increase in intracellular sodium. Finally, this compound increases intracellular calcium through the Na ÷/Ca z÷ exchange mech- 479 anism. The mechanism of action of DPI is reported to involve neither the stimulation of fi-adrenoceptors nor inhibition of phosphodiesterase. This agent also has electrophysiological properties similar to class III antiarrhythmic agents which prolong the myocardial action potential duration with little depression of Vmax (maximal rate of rise of action potential) (Scholtysik et al. 1985) . It is, therefore, of great interest to evaluate the antiarrhythmic potential of this agent in the failing heart.
The main purpose of the present study was to assess the advantage of DPI in comparison to dobutamine on cardiac electrophysiology and arrhythmias in the dog with ischemically injured myocardium which would exist in many patients with heart failure. That is to say, the present post-infarction dog was not used as an animal model of heart failure, but rather as a model for investigating the effect of positive inotropic intervention in an animal with the arrhythmogenic risk factor. In the present study, the assessment of hemodynamic effects of both drugs was carried out in order to find out the dose of DPI equipotent to the clinical dose of dobutamine.
Materials and methods

Animalpreparation.
Mongrel dogs weighing between 6.0 and 15.0 kg were anesthetized with intravenous sodium pentobarbital (30 mg/ kg). Each animal was intubated and ventilated with room air using a constant volume-cycled respirator. A thoracotomy was made with sterile techniques in the left fourth intercostal space, and the heart was exposed. The pericardium was opened, and the left anterior descending coronary artery (LAD) was isolated from the surrounding tissues and ligated with two silk ligatures just distal to the first diagonal branch using the Harris' two-stage procedure (Harris 1950) . In some cases, usually two small diagonal branches of the LAD appearing to provide collateral blood flow between the circumflex coronary artery and distal LAD were ligated. The chest was closed immediately after the LAD ligation, and then, the animals were allowed to recover from surgical stress. Routine postoperative care including prophylactic antibiotic therapy (ceftizoxime, 500 rag/ kg/day, i.v.) was administered. Dogs which survived and regained regular sinus rhythm 5 to 7 days after the surgery were divided into the three groups for the following hemodynamic study (n = 7), cardiac electrophysiological study (n = 6), and arrhythmia testing (n = 26). Fourteen dogs subjected to sham-operation (the chest and pericardium were opened, but the LAD was not ligated) were also provided for the hemodynamic study.
Measurements of hemodynamic parameters. The effects of DPI and dobutamine on the hemodynamic parameters in dogs which survived 5 to 7 days after the LAD ligation were determined. The baseline values of the hemodynamie parameters were also measured in normal dog hearts with sham-operation. Dogs were anesthetized with intravenous sodium pentobarbital (30 mg/kg), and ventilation and thoracotomy were performed as described above. Body temperature was maintained at 37-38°C with a heating pad. The pericardium was opened and the heart was suspended in a pericardial cradle. Two flow probes connected with a 2-channel ultrasonic Doppler flowmeter (Transonic Systems Inc., NY, USA, T201) were placed around the ascending aorta and the proximal left circumflex coronary artery for the measurement of cardiac output and blood flow of left circumflex coronary artery, respectively. Arterial blood pressure was measured with a pressure transducer (Gould, CA, USA, P50) connected with a fluid-filled polyethylene catheter inserted into the right femoral artery. Left ventricular pressure was measured with a 5F micromanometer-tipped catheter (Millar Instruments, TX, USA, PC350) inserted from the left common carotid artery, and the rate of rise of left ventricular pressure (LV dp/dt) was calculated with an electronic differentiator (Nihon Khoden, Tokyo, Japan, ED-600G). Heart rate was triggered from a standard limb lead II of electrocardiogram (ECG) using a cardiotachometer (Nihon Khoden, AT-600G). All pressure and flow measurements and electrocardiographic signals for analysis were recorded on a multi-channel thermal-array recorder (Nihon Kohden, WS-682G) at a paper speed of 10 mm/min or 50-200 mm/s where appropriate.
Measurements of ventricular conduction time and effective refractory period. Dogs, 5 to 7 days after the LAD ligation (see above) were used. The heart was cradled in the opened pericardium, and an lead-II ECG was continuously monitored on a multi-channel oscilloscope (Nihon Khoden, VM-680G). Two bipolar electrodes (insulated silver wire attached to an acryl plate, 0.2 mm in diameter, 3 mm apart) were placed on the surface of the left ventricle for the determination of the epicardial ECG; one was over the normal myoeardium in the perfusion area of left circumflex coronary artery (normal zone) and the other was over chronically ischemic myocardium in the perfusion area of occluded left anterior descending coronary artery (infarcted zone). Two additional bipolar electrodes were also attached to the surface of the right ventricular outflow tract (RVOT) for ventricular extrastimulation and on the left atrial appendage for atrial pacing, respectively (Fig. 1) . Electrical stimulation of the RVOT and the left atrial appendage was made with a 5 ms rectangular pulse and a strength twice as large as the diastolic threshold. Atrial pacing was introduced with a basic cycle length of 350 ms throughout the electrophysiological studies. The left ventrieular conduction time and effective refractory period (ERP) were measured by the extrastimulus technique with the use of a 3-channel programmable electric stimulator (Nihon Khoden, SEN-7103) and a stimulus isolator (Nihon Khoden, SS-102J). A ventricular extrastimulus was triggered from the R-wave of lead-II ECG immediately after a train of ten atrial pacing stimuli (S1). An extrastimulus ($2) was delivered into the RVOT with SI-$2 coupling intervals of 250, 200 and 150 ms in order to measure the ventrieular conduction time, which was defined by the interval between the artifact of $2 and the most delayed measurable spike of the conducted $2 on the epicardial ECG. The ERP at the electrode sites in non-infarcted and infarcted ventricular myocardia were measured with the modified methods described by Michelson et al. (1980) . Late diastolic thresholds at the test sites were measured and, if they varied by more than 0.5 mA, the data were discarded. During atrial pacing, a late extrastimulus ($2; 5 ms in duration, at twice the diastolic threshold) that was able to produce a propagated ventricular response was introduced into the test site, and then the $1-$2 interval was shortened in steps of 2 or 10 ms, where appropriate, until $2 failed to produce a propagated ventricular response. The ERP was defined as the longest SI-$2 interval that failed to produce a propagated ventricular response at a maximum current of 4 mA.
Programmed electrical ventricular stimulation (PES). Dogs sub-
jected to the LAD ligation (see above) were anesthetized with intravenous pentobarbital and treated as described above. The epicardial ECG in non-infarcted and infarcted zones were continuously monitored together with lead-II ECG on a multi-channel oscilloscope (Nihon Kohden, VM-680G). After a train of ten atrial pacing stimuli (S 1), a single extrastimulus ($2) was delivered into the RVOT with an S1-$2 interval of 200 ms or less in steps ofl0 ms. If $2 failed to induce any spontaneous ventricular beat following a ventricular response of $2, double extrastimuli ($2 and $3) were delivered with an $2-$3 interval of 200 ms or less in the setting of the SI-$2 interval that exceeded the effective refractory period by 10 ms. The procedure was repeated with double or triple ($2, $3 and $4) extrastimuli until spontaneous ventricular beats could be reproducibly induced. The incidence of ventricular arrhythmias was defined as follows: Sustained ventricular tachycardia was considered as a run of ventricular tachycardia (VT) that lasted for 15 s, that is, this was artificially terminated 15 s later by flipping the ventricle or by a short run of ventricular electrical stimulation to avoid a reduction in cardiac performance and an elevation of sympathetic tone in Protocol for drug administration. Each of 7 dogs for the hemodynamic study and 6 dogs for the cardiac electrophysi01ogical study was given both dobutamine and DPI to compare precisely the responses of these parameters to the two drugs. Dobutamine was applied first because a rapid return to the baseline values occurred owing to its short half-life of elimination. After the measurement of control data, dobutamine was given intravenously with progressively increasing rate of infusion of 3, 5, and 10 gg/kg/min each for 10 rain. The hemodynamic or electrophysiological parameters were measured at the end of each rate of dobutamine infusion. After the baseline values were reached (usually after a 30 rain rest period), consecutive doses of 1 + 2 + 2 mg/kg (1, 3, and 5 mg/kg, in total) of DPI were given intravenously at 5 rain intervals, and then measurements were performed 4 rain after the administration of each dose. Since in our preliminary study with post-infarction dogs it had been revealed that a small amount of dimethyl sulfoxide (0A ml/kg) which corresponded to the maximal dose of DPI (5 mg/kg) was ineffective on both hemodynamic and cardiac electrophysiological parameters (data were not shown), the present study was not designed to assess the effects of the vehicle alone on these parameters. For the PES study, 26 dogs were divided into the three treatmentgroups; DPI (n = 10), dimethyl sulfoxide (n = 6), and dobutamine (n = 10). We used higher doses of DPI (3 and 5 mg/kg, in total) and dobutamine (5 and 10 p.g/kg/min), which had been large enough to improve the depressed hemodynamic parameters to the control values in the preceding hemodynamic characterization. After determination of baseline inducibility of ventricular arrhythmias by PES, consecutive doses of DPI (3 and + 2 mg/kg) or dimethyl sulfoxide . (0.04 and + 0.06 ml/kg) were given at 5 rain intervals, and then PES testing was performed between 3 to 5 rain after the administration of each dose. Dobutamine was given intravenously at rates of 5 and 10 gg/kg/min each for 10 min. PES testing was performed at the end of each rate of the infusion. In addition, DPI-, dimethyl sulfoxide-, and dobutamine-treated dogs underwent subsequent postmortem determination of necrosis size.
Determination of myocardial necrosis size. After the PES study, Evans blue dye (100 ml of 1% solution) was injected intravenously to determine the chronically ischemic area, i.e. infarcted zone and to ascertain the position of each epicardial electrode. Cardiac standstill was then induced by injecting an overdose of pentobarbital. The heart was rapidly removed and sectioned in transverse rings 1.0 cm thick successively from apex to base. The tissue slices were rinsed in cold physiological saline and then incubated at 38°C for 20 rain in Values are expressed as means _+ SEM. MABP, mean arterial blood pressure; peak LV dp/dt, maximal rate of rise of left ventricular pressure; LVEDP, left ventricular end-diastolic pressure; LCX flow, blood flow of the left circumflex coronary artery * P < 0.05 as compared with the control values 1% solution of triphenyl tetrazolium chloride in phosphate buffer. This produces a bright red coloration in the presence of dehydrogenase enzymes in non-necrotic myocardium, whereas necrotic regions remain unstained. The areas of necrosis and non-necrosis were then traced on an acetate sheet. The drawing of the myocardial rings of the myocardium were then re-traced on a graph paper and the area of necrosis as well as that of the total ventricle were quantified by weighing.
Drugs.
hydroxypropoxyl]-lH-indole-2-carbonitrile) was kindly provided by Sandoz Co., Ltd., Basel, Switzerland. The compound was dissolved in a small amount of dimethyl sulfoxide (0.02 ml/mg of DPI). (_)-Dobutamine (Dobutrex, Shionogi Co., Ltd., Japan) was dissolved in physiological saline at the concentration of 0.1 rag/rot. ing 10 dogs died of lethal ventricular arrhythmias mostly within 24 h after the surgery. All of the survivors had regained regular sinus rhythm within 5 days after the surgery, however 3 out of them were excluded for the subsequent studies because of post-operative infection.
Effects of DPI and dobutamine on the hemodynamics of the dog with subacute myocardial infarction
Baseline values of hemodynamic parameters in 7 dogs with infarcted myocardium are compared with those in 14 normal dogs with sham-operation (Table 1) . Peak LV dp/dt in the infarcted heart was significantly lower ( -2 1 % ) than that in the normal heart. Left ventricular end-diastolic pressure was approximately doubled, while cardiac output as well as stroke volume was decreased by about 20% in the infarcted heart, though not significant. The effects of cumulative i.v. bolus injections of DPI (1 -5 mg/kg) and i. v. infusion ofdobutamine (3 to 10 tag/ kg/min) were evaluated in 7 anesthetized dogs with myocardial infarction. Figure 2 depicts the changes in hemodynamic parameters after different doses of these agents were administered to dogs with myocardial infarction. DPI produced dose-dependent increases in peak LV dp/dt and stroke volume, whereas cardiac output did not significantly change due to a marked decrease in heart rate. DPI also did not change left ventricular end-diastolic pressure. The administration of DPI (3 and 5 rag/ kg) restored peak LV dp/dt (from 2250_+ 190 to 2960 __ 230 and to 3150 _+ 210 mm Hg/s) even beyond the control value (2790 _+ 160 mm Hg/s). Stroke volume was also normalized by the administration of 5 mg/kg (from 4.4_+0.5 to 5.6±0.6ml/min; the control value 5.9 _+ 0.6 ml/min). At that time the blood flow of left circumflex coronary artery did not significantly change.
In contrast, dobutamine increased dose-dependently all hemodynamic parameters. Such parameters representing failing left ventricular function, as peak LV dp/ dt, cardiac output, and stroke volume were restored to normal values or even overshot at doses greater than 5 gg/kg/min dobutamine, whereas left ventricular enddiastolic pressure was slightly but significantly increased at higher doses.
Electrophysiological effects of DPI and dobutamine
Effects of DPI and dobutamine on the epicardial ECG in the non-infarcted and infarcted zones of left ventricular myocardium were compared by measuring the epicardial ventricular conduction, ventricular excitation threshold, and ERP using 6 dogs with infarcted myocardium. The results are summarized in Tables 2 and 3 . In all cases, fractionated late potentials indicating the intraventricular conduction (or excitation) delay were observed in the infarcted zone, particularly within 5 to 10 mm of the border between the non-infarcted and infarcted zones (Fig. I right panel and Fig. 3 control) . The conduction time and ERP measured in the infarcted zone was longer than those in the non-infarcted zone, and the excitation threshold in the former was almost doubled (Table 2 and 3, control). The conduction time measured in the infarcted zone was increased dose-dependently by the CI, coupling interval of the ventricular extrastimulation; ERP, effective refractory period; ERPnz, ERP in the non-infarcted zone; ERPiz, ERP in the infarcted zone. Values are expressed as means ± SEM of 6 dogs * P < 0.05, ** P < 0.01, as compared with the control values CI, coupling interval of the ventricular extrastimulation; ERP, effective refractory period; ERPnz, ERP in the non-infarcted zone; ERPiz, ERP in the infarcted zone. Values are expressed as means ± SEM of 6 dogs * P < 0.05, ** P < 0.01, as compared with the control values administration of DPI (1 -5 mg/kg) at any coupling intervals of extrastimulus ($2) of 150, 200 and 250 ms, and significant changes were observed at higher doses. The conduction time in the non-infarcted myocardium was also increased, but significant changes were observed only at the $2 coupling interval of 150 ms with higher doses (Table 2) . Thus, these effects were gradually enlarged as the coupling interval was shortened to be close to the ERP value. In contrast to DPI, dobutamine had no effect on the ventricular conduction time in both non-infarcted and infarcted myocardia. A typical effect of DPI on the delayed intraventricular conduction in the infarcted zone is illustrated in Fig. 3 . DPI (1-5 mg/kg) resulted in dose-dependent increases in the ERP of both non-infarcted and infarcted sites to a similar extent. In contrast, the infusion of dobutamine (3-10 gg/kg/min) produced significant decreases in the ERP heterogenously in the non-infarcted and infarcted sites, leading to a larger difference in the ERP between the both sites than before the drug administration (Table 3 ). In addition, the ERP measured at the RVOT increased from 113 + 3 ms to 131 _+ 5 ms (P<0.01) and to 137±5ms (P<0.01) after the administration of 3 and 5 mg/kg DPI, respectively, and decreased from 113 ___ 2 ms to 107 __ 2 ms (P < 0.05) and 102 + 2 ms (P < 0.01) after infusion of 5 and 10 gg/kg/ rain, respectively.
Effects of DPI and dobutamine on the incidence of ventricular tachyarrhythmias induced by PES
The higher doses of DPI (3 and 5mg/kg) and of dobutamine (5 and i 0 ~tg/kg/min), which were needed to restore the left ventricular dysfunction associated with the subacute myocardial infarction as mentioned above, were administered to 10 dogs with myocardial infarction in order to evaluate the effects of these agents on the inducibility of ventricular tachyarrhythmias produced by PES.
At the control (pre-drug) PES in the case of DPI, 6 out of 10 dogs exhibited either non-sustained (n = 4) or sustained VT (n = 2), while VT could not be induced in the other 4 dogs. In 4 out of 6 dogs, in which VT was elicited at the control PES, the reinducible VT (3 nonsustained and i sustained VT) was significantly abolished by the administration of 3 mg/kg DPI (P < 0.05 as compared with the pre-drug state; Fisher's exact test). The increases of DPI up to 5 mg/kg showed no further improvement. A representative experiment is shown in Fig. 4 . No worsening of arrhythmias was observed in the 4 dogs, in which no VT could be induced by PES before drug administration, even after the highest dose of DPI (Fig. 5, left panel) .
In the case of dimethyl sulfoxide, the control PES elicited sustained VT in 2 out of 6 dogs and non-sustained VT in the remaining 4 dogs. The reinducibility of VT was not changed by the administration of 0.06 and + 0.04 ml/ kg of dimethyl sulfoxide.
At the control PES in the case of dobutamine, 4 out of 10 dogs had VT (2 non-sustained and 2 sustained VT), while VT could not be induced in the other 6 dogs. Administration of 5 ~tg/kg/min of dobutamine gave rise to non-sustained VT in one of 6 non-inducible dogs and the further increase of dose to 10 tag/kg/min converted the non-sustained VT to sustained VT in this dog. The highest dose of dobutamine induced tachyarrhythmias (1 non-sustained VT and 1 sustained VT) in the remaining two non-inducible animals, and converted the non-sustained VT to sustained VT in one of two dogs, in which non-sustained VT was elicited by PES before and after administration of 5 gg/kg/min of dobutamine (Fig. 5,  right panel) .
The myocardial necrosis sizes of DPI-, dimethyl sulfoxide-, and dobutamine-treated animals were 32.5% ±5.4% (n=10), 33.2%±7.1% (n=6), and 29.6% i 6.2% (n = 10) of the whole ventricle, respectively, and there was no significant difference among the three treatment-groups.
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Discussion
In the present study, the effects on hemodynamics, cardiac electrophysiology, and PES-induced arrhythmias of a new cardiotonic agent (DPI) in comparison with a conventional one (dobutamine) were evaluated in dogs with left ventricular dysfunction associated with subacute myocardial infarction, which is representative of the clinical indication for these agents. The positive inotropic actions and hemodynamic effects of DPI and dobutamine have been previously demonstrated both in intact animals (Salzmann et al. 1986; Tuttle and Mills 1975) and in animals with acute heart failure (Siegl and Wenger 1986; Willerson et al. 1976 ). However, hemodynamic responses to these agents in animals with left ventricular dysfunction due to chronic, regional ischemia have never been reported. In this study, the dogs which survived 5 to 7 days after the occlusion of the LAD showed a significant decrease in peak LV dp/ dt by about 20%, whereas the changes in cardiac output, stroke volume (about -2 0 % , respectively) and left ventricular end-diastolic pressure (about + 100%) were not significant, suggesting the survivors of post-infarction dogs showed relatively mild pump failure in the subacute phase after the LAD ligation. The higher doses of DPI ( > 3 mg/kg i. v.) improved the depressed cardiac function even over the control level and these effects were as large as those observed at clinical doses (5 to 10 gg/kg/min) of dobutamine. This result for DPI is closely related to the clinical beneficial effect on the hemodynamics in patients with chronic, moderate cardiac failure (Hogan et al. 1988) . On the other hand, higher doses of DPI were used in the present study than those used in recent animal experiments (Gerard et al. 1989 (Gerard et al. , 1990 ). For instance, 0.3 mg/kg of racemic DPI, which was equipotent to 5 lag/ kg/min of dobutamine, exhibited an increase in LV dp/ dt by 20% in conscious dogs (Gerard et al. 1989) . It is unclear why the hemodynamic response to DPI in our study was lesser than that in the previous study, however, the response to this agent might have been modified in the presence of anesthetics and myocardial infarction.
Electrophysiological studies in vitro using conventional microelectrodes have shown that DPI preferentially prolongs the action potential duration and slightly decreases Vmax (Scholtysik et al. 1985) , indicating that this compound may act as class III antiarrhythmic (Mortensen et al. 1989) . In fact, Scholtysik and Williams (1986) reported that DPI inhibited aconitine-induced arrhythmias and those associated with the coronary artery ligation-reperfusion in rats. However, no further information has been so far available on the antiarrhythmic action of DPI. In the present study, the PES technique was used to determine if the antiarrhythmic action of DPI may be associated with the cardiotonic activity within the same effective range of doses in the 5 to 7 days postinfarction dogs and to compare its action with dobutamine which, unlike DPI, shortens action potential duration. The primary mechanism of PES-induced experimental ventricular arrhythmias in animals with subacute myocardial infarction is probably re-entry (E1- Sherif et al. 1977a) , whose initiating factors may be the heterogenic distribution of myocardial refractoriness as well as the delayed intraventricular conduction (Michelson et al. 1980) . The pharmacological intervention of these arrhythmias is highly predictive of a clinical response (Josephson et al. 1980 ) and, therefore, many workers have used this method for evaluating antiarrhythmics (Patterson et al. 1984; Marinchak et al. 1989) , cardiotonics (Lynch et al. 1989) , and other cardioactive agents (Lynch et al. 1986 ). In the present study, DPI significantly inhibited the incidence of ventricular tachyarrhythmias evoked by PES and also increased the ERP equally in both non-infarcted and infarcted zones. Previous investigations with the other agents having class III antiarrhythmic properties such as sotalol (Patterson et al. 1984) and amiodarone (Marinchak et al. 1989) have demonstrated that these compounds are markedly effective in suppressing the re-entrant ventricular tachyarrhythmias induced by PES in the subacute or chronic infarction model, and these effects are attributed to an increase in myocardial refractoriness. Furthermore, Lynch et al. (1986) suggested that the ability of drugs to increase the refractoriness in the non-infarcted zone as well as that in the infarcted zone might serve to hinder the exit of re-entrant waves of depolarization from the infarcted zone to the non-infarcted zone. This concept strongly supports our speculation that the antiarrhythmic activity of DPI observed in this PES study may be attributable to the equal increase in ventricular refractoriness of both the two zones.
Previous reports have suggested that the stimulation of cardiac fl-adrenoceptors causes an accelerated repolarization to shorten the action potential duration (Vaughan Williams 1985) , resulting in a reduction of refractoriness that may predispose to the formation of a re-entry circuit (Wellens et al. 1984 ). In the ischemic heart this may contribute to the development of ventricular arrhythmias by promoting the heterogeneity of refractoriness within the myocardium, especially between nonischemic and ischemic zones (Vaughan Williams 1985) . In this study, dobutamine was shown to decrease the ERP in the non-infarcted myocardium to a greater extent than in the infarcted myocardium, leading to an increase in the heterogeneity of refractoriness, in other words, production of proarrhythmic state. In fact, dobutamine tended to worsen the PES-induced arrhythmias. Furthermore, biochemical studies suggest that an increase in intracellular cAMP which mediates cardiotonic actions of fl-adrenoceptor agonist inherently possesses an arrhythmogenic property (Lubbe et al. 1978) . DPI is reported not to be associated with an increase in intracellular cAMP (Scholtysik et al. 1985) . This may be also attributable to the findings that DPI, unlike dobutamine, did not possess any arrhythmogenic activity in our PES study.
In the present study, fractionated epicardial potentials were observed in the infarcted myocardium, which implied the occurrence of delayed conduction within this zone (Fig. 1 IZeg) . The delayed conduction in the infarcted zone is one of the important factors for the initiation of re-entrant tachyarrhythmias (E1- Sherif et al. 1977a; Wellens et al. 1984; Josephson et al. 1978) . Furthermore, there is some evidence that drugs which depress the delayed conduction in the infarcted ventricular myocardium can suppress the induction of re-entrant ventricular arrhythmias by PES, while there is also the possibility that these drugs may aggravate the arrhythmias in response to PES by establishing a new re-entrant pathway (E1- Sherif et al. 1977b) . In this study, DPI depressed the delayed conduction in the infarcted zone in a frequencydependent manner. The conduction in the non-infarcted myocardium was slightly, but significantly, depressed only at the premature excitation whose coupling interval was close to the ERP. This observation indicates that this agent may inhibit the conduction of ischemicallydepolarized ventricular myocardium or prematurely excited one in a way similar to lidocaine (Kupersmith et al. 1975) . Although the exact mechanism for this action of DPI on the conduction is unclear, this may, in part, account for its depressive effect on the incidence of reentrant ventricular arrhythmias by PES.
Previous experimental animal (Gloor and Kappenberger 1985) and clinical studies (Butrous et al. 1988; Walker et al. 1989) have shown the significant prolongation of the QT and QTc interval of ECG by DPI. On the other hand, Schoeller et al. (1989) reported that DPI might have produced increased ventricular arrhythmias, cardiogenic shock, and sudden death in patients with advanced cardiac insufficiency in spite of its remarkable hemodynamic efficacy. In the present study, in some preparations DPI also evoked transient episodes of spontaneous ventricular ectopic beats. These arrhythmias may be due to bradycardia-dependent, early afterdepolarization and triggered activity (Brachmann et al. 1983; E1-Sherif et al. 1988 ) because they were suppressed readily by atrial or ventricular pacing. Thus, it remains controversial whether the prolongation of action potential dur-ation and the resultant prolongation of QT interval in ECG, which are the predominant electrophysiological and electrocardiographic effects of DPI, will be advantageous to patients with heart failure. In the present study, DPI was shown to have only "prophylactic" effects on arrhythmias in the setting of subacute myocardial infarction. Therefore, further studies are needed to clarify whether this agent actually prevents existing arrhythmias due to a mechanism such as class III activity.
In conclusion, mild cardiac failure and ventricular tachyarrhythmias induced by PES were exhibited in the 5 to 7 days post-infarction dogs in this study. DPI, unlike dobutamine, suppressed re-entrant ventricular arrhythmias induced by PES within the same range of doses which produced favorable hemodynamic changes to improve left ventricular dysfunction. The beneficial effect of DPI on cardiac arrhythmias in the present animal preparation may contribute to the non-heterogeneous increase in refractoriness in both non-injured normal and ischemically injured ventricular myocardium. Thus, the class III properties of DPI observed in this study indicate that it may have potential as a cardiotonic drug for treatment of cardiac failure in patients with ischemically injured myocardium.
